NCT03897543 - ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2023

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

ABX196

ABX196 will be administered as an IM injection 120 minutes (+/- 15 minutes) after the completion of the nivolumab infusion on Day 1 of every other 28-Day treatment cycle (i.e., every 8 weeks).

Trial Locations (2)

77030

RECRUITING

MD Anderson Cancer Center, Houston

92037

RECRUITING

Scripps Clinic Torrey Pines, La Jolla